CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICE
The article reviews the use of cardiac glycosides in patients with chronic heart failure, paroxysmal tachyarrhythmia and chronic atrial fibrillation (rate control). According to the recent studies results cardiac glycosides may be substituted by angiotensin-converting enzyme inhibitors, angiotensin...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
MONIKI
2016-02-01
|
| Series: | Alʹmanah Kliničeskoj Mediciny |
| Subjects: | |
| Online Access: | https://www.almclinmed.ru/jour/article/view/181 |
| _version_ | 1818623402684973056 |
|---|---|
| author | M. A. Gurevich A. A. Gavrilin |
| author_facet | M. A. Gurevich A. A. Gavrilin |
| author_sort | M. A. Gurevich |
| collection | DOAJ |
| description | The article reviews the use of cardiac glycosides in patients with chronic heart failure, paroxysmal tachyarrhythmia and chronic atrial fibrillation (rate control). According to the recent studies results cardiac glycosides may be substituted by angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, diuretics, calcium antagonists and beta-adrenoceptor blockers in order to decrease the risk of cardiac glycoside toxicity and, in some cases, to improve quality of life and prognosis of the patients. |
| first_indexed | 2024-12-16T18:40:30Z |
| format | Article |
| id | doaj.art-2f5945bad48f4f9581df1c615f1864b3 |
| institution | Directory Open Access Journal |
| issn | 2072-0505 2587-9294 |
| language | Russian |
| last_indexed | 2024-12-16T18:40:30Z |
| publishDate | 2016-02-01 |
| publisher | MONIKI |
| record_format | Article |
| series | Alʹmanah Kliničeskoj Mediciny |
| spelling | doaj.art-2f5945bad48f4f9581df1c615f1864b32022-12-21T22:21:03ZrusMONIKIAlʹmanah Kliničeskoj Mediciny2072-05052587-92942016-02-0103510110510.18786/2072-0505-2014-35-101-105181CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICEM. A. Gurevich0A. A. Gavrilin1Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian FederationMoscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian FederationThe article reviews the use of cardiac glycosides in patients with chronic heart failure, paroxysmal tachyarrhythmia and chronic atrial fibrillation (rate control). According to the recent studies results cardiac glycosides may be substituted by angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, diuretics, calcium antagonists and beta-adrenoceptor blockers in order to decrease the risk of cardiac glycoside toxicity and, in some cases, to improve quality of life and prognosis of the patients.https://www.almclinmed.ru/jour/article/view/181cardiac glycosidesdigoxinchronic heart failureatrial fibrillationangiotensin-converting enzyme inhibitorszofenoprilverapamilesmolollandiolol |
| spellingShingle | M. A. Gurevich A. A. Gavrilin CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICE Alʹmanah Kliničeskoj Mediciny cardiac glycosides digoxin chronic heart failure atrial fibrillation angiotensin-converting enzyme inhibitors zofenopril verapamil esmolol landiolol |
| title | CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICE |
| title_full | CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICE |
| title_fullStr | CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICE |
| title_full_unstemmed | CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICE |
| title_short | CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICE |
| title_sort | cardiac glycosides in up to date clinical practice |
| topic | cardiac glycosides digoxin chronic heart failure atrial fibrillation angiotensin-converting enzyme inhibitors zofenopril verapamil esmolol landiolol |
| url | https://www.almclinmed.ru/jour/article/view/181 |
| work_keys_str_mv | AT magurevich cardiacglycosidesinuptodateclinicalpractice AT aagavrilin cardiacglycosidesinuptodateclinicalpractice |